Get the Stockscreener App
9.49
0.21%
0.02
After Hours:
9.49
Enfusion Inc stock is traded at $9.49, with a volume of 145.34K.
It is up +0.21% in the last 24 hours and up +14.48% over the past month.
Enfusion Inc is a software-as-a-service (SaaS) provider focused on transforming the investment management industry. Its solutions are designed to eliminate technology and information barriers, empowering investment managers to make and execute an informed investment decisions in real-time. It simplifies investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset resulting in a single source of truth. It generates maximum revenue from Americas, followed by Asia Pacific and Europe, Middle East, and Africa.
See More
Previous Close:
$9.47
Open:
$9.4
24h Volume:
145.34K
Relative Volume:
0.38
Market Cap:
$882.71M
Revenue:
$174.54M
Net Income/Loss:
$6.03M
P/E Ratio:
118.62
EPS:
0.08
Net Cash Flow:
$15.96M
1W Performance:
-0.11%
1M Performance:
+14.48%
6M Performance:
+2.59%
1Y Performance:
+5.80%
1-Day Range:
$9.38
$9.52
1-Week Range:
$9.355
$9.77
52-Week Range:
$7.52
$10.45
Enfusion Inc Stock (ENFN) Company Profile
Name
Enfusion Inc
Sector
Industry
Phone
(312) 253-9800
Address
125 SOUTH CLARK STREET, SUITE 750, CHICAGO
Enfusion Inc Stock (ENFN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-03-23 | Initiated | Piper Sandler | Neutral |
| Mar-15-23 | Initiated | JP Morgan | Neutral |
| Jan-04-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-03-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-15-21 | Initiated | BofA Securities | Buy |
| Nov-15-21 | Initiated | Credit Suisse | Neutral |
| Nov-15-21 | Initiated | Goldman | Neutral |
| Nov-15-21 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-21 | Initiated | Piper Sandler | Overweight |
| Nov-15-21 | Initiated | Stifel | Buy |
| Nov-15-21 | Initiated | William Blair | Outperform |
View All
Enfusion Inc Stock (ENFN) Latest News
Where are the Opportunities in (ENFN) - Stock Traders Daily
Clearline Capital LP Sells 70,738 Shares of Enfusion, Inc. (NYSE:ENFN) - MarketBeat
Exclusive-Financial software maker Enfusion explores options including sale, sources say - AOL
Enfusion (ENFN) Moves 5.0% Higher: Will This Strength Last? - MSN
Logos Global Management LP Lowers Holdings in Enliven Therapeutics, Inc. (NASDAQ:ELVN) - Defense World
Enlivex Progresses to Phase II for Knee Arthritis Treatment - TipRanks
Enfusion, Inc. (NYSE:ENFN) Shares Purchased by Scalar Gauge Management LLC - MarketBeat
Check Out Enfusion Inc (ENFN)’s Trade Data Rather Than the Analysts’ Views - SETE News
ENFN’s Market Balancing Act: Weighing Gains and Losses in 2023 - The InvestChronicle
Enfusion (NYSE:ENFN) Stock Price Up 4.3% - MarketBeat
ENFNEnfusion, Inc. Latest Stock News & Market Updates - StockTitan
Enfusion (ENFN) Moves 5.0% Higher: Will This Strength Last? - Yahoo Finance
Enfusion in discussions with bankers amid takeover interestReuters - MSN
Enfusion Reportedly in Talks with Investment Bankers to Evaluate Options, Including a Potential Sale - Marketscreener.com
Financial software maker Enfusion explores options including sale, sources say - The Economic Times
Enfusion (NYSE:ENFN) Sees Large Volume Increase - MarketBeat
Exclusive-Financial software maker Enfusion explores options including sale, sources say - WHBL
Exclusive: Financial software maker Enfusion explores options including sale, sources say - Reuters
Enfusion Mulls Sale Amid Takeover Interest and Market Pressures - Devdiscourse
Exclusive-Financial software maker Enfusion explores options including sale, sources say - CNA
Financial software maker Enfusion explores options including sale, sources say - TradingView
Reviewing Enfusion (NYSE:ENFN) and Advanced Credit Technologies (OTCMKTS:ACRT) - Defense World
Enliven Therapeutics (NASDAQ:ELVN) Trading Up 8.3% - MarketBeat
Arizona State Retirement System Invests $86,000 in Enfusion, Inc. (NYSE:ENFN) - Defense World
(ENFN) Technical Pivots with Risk Controls - Stock Traders Daily
Enfusion, Inc. (NYSE:ENFN) Short Interest Update - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enfusion, Inc.ENFN - PR Newswire
Implied Volatility Surging for Enfusion (ENFN) Stock Options - MSN
Implied Volatility Surging for Enfusion (ENFN) Stock Options - Zacks Investment Research
Implied Volatility Surging for Enfusion (ENFN) Stock Options - Yahoo Finance
Enfusion Inc [ENFN] Shares Fall -0.50 % on Wednesday - Knox Daily
ENFN Investors Have Opportunity to Join Enfusion, Inc. Securities Fraud Investigation with the Schall Law Firm - Business Wire
(ENFN) Long Term Investment Analysis - Stock Traders Daily
Deirdre Somers appointed independent director of Enfusion, Inc. - Yahoo Finance UK
CXM: 3 Tech Stocks Under $10 With Massive Upside Potential - StockNews.com
Short Interest in Enfusion, Inc. (NYSE:ENFN) Expands By 19.1% - MarketBeat
Enfusion Inc [ENFN] Chief Accounting Officer makes an insider purchase of 1,258 shares worth 10278.0. - Knox Daily
Should You Believe in Enfusion’s (ENFN) Healthy Revenue Growth And Margin Expansion in the Future? - Yahoo Finance
Should You Believe in Enfusion's (ENFN) Healthy Revenue Growth And Margin Expansion in the Future? - MSN
ENFN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Clients to Contact the Firm! - AccessWire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & - GlobeNewswire
ENFN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Investors to Contact the Firm Today! - AccessWire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - Business Wire
ENFN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Investors to Contact the Firm Today! - AccessWire
Enfusion: Growth Should Accelerate In Coming Quarters (NYSE:ENFN) - Seeking Alpha
California State Teachers Retirement System Has $333,000 Position in Enfusion, Inc. (NYSE:ENFN) - Defense World
Price T Rowe Associates Inc. MD Takes Position in Enfusion, Inc. (NYSE:ENFN) - Defense World
ENFN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Enfusion, Inc. and Encourages Shareholders to Contact the Firm! - AccessWire
Enfusion, Inc. (ENFN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - businesswire.com
Investors Can Find Comfort In Enfusion's (NYSE:ENFN) Earnings Quality - Simply Wall St
Investors Can Find Comfort In Enfusion's (NYSE:ENFN) Earnings Quality - Yahoo Finance
Enfusion Inc Stock (ENFN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.32%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):